Exact Mass: 533.1629736000001
Exact Mass Matches: 533.1629736000001
Found 161 metabolites which its exact mass value is equals to given mass value 533.1629736000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N-(3,4-Dichlorophenyl)-2-{[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]oxy}acetamide
(2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol
C23H30F3N3O4S2 (533.1629736000001)
Pelargonidin 3-(6'-succinyl-glucoside)
Pelargonidin 3-(6-succinyl-glucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Pelargonidin 3-(6-succinyl-glucoside) is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Pelargonidin 3-(6-succinyl-glucoside) can be found in cloudberry, red raspberry, strawberry, and wheat, which makes pelargonidin 3-(6-succinyl-glucoside) a potential biomarker for the consumption of these food products.
7-[(beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranosyl)oxymethy]-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione
14-Deoxy-12-(cysteine-S-yl)-andrographolide-3-O-sulfate
C23H35NO9S2 (533.1753140000001)
1,2,3,10-Tetramethoxy-9-(2-hydroxy-4,5-dimethoxybenzyloxy)oxoaporphine
4-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoic acid
C27H32ClNO8 (533.1816342000001)
Ala Glu Glu Trp
Ala Glu Trp Glu
Ala Trp Glu Glu
Cys Glu Pro Trp
Cys Glu Trp Pro
Cys Phe His Gln
Cys Phe Gln His
Cys His Phe Gln
Cys His Gln Phe
Cys Pro Glu Trp
Cys Pro Trp Glu
Cys Gln Phe His
Cys Gln His Phe
Cys Trp Glu Pro
Cys Trp Pro Glu
Asp Asp Glu Arg
Asp Asp Arg Glu
Asp Asp Val Trp
Asp Asp Trp Val
Asp Glu Asp Arg
Asp Glu Arg Asp
Asp Arg Asp Glu
Asp Arg Glu Asp
Asp Val Asp Trp
Asp Val Trp Asp
Asp Trp Asp Val
Asp Trp Val Asp
Glu Ala Glu Trp
Glu Ala Trp Glu
Glu Cys Pro Trp
Glu Cys Trp Pro
Glu Asp Asp Arg
Glu Asp Arg Asp
Glu Glu Ala Trp
Glu Glu Glu Gln
Glu Glu Gln Glu
Glu Glu Trp Ala
Glu Pro Cys Trp
Glu Pro Trp Cys
Glu Gln Glu Glu
Glu Arg Asp Asp
Glu Trp Ala Glu
Glu Trp Cys Pro
Glu Trp Glu Ala
Glu Trp Pro Cys
Phe Cys His Gln
Phe Cys Gln His
Phe His Cys Gln
Phe His Gln Cys
Phe Gln Cys His
Phe Gln His Cys
His Cys Phe Gln
His Cys Gln Phe
His Phe Cys Gln
His Phe Gln Cys
His Gln Cys Phe
His Gln Phe Cys
Pro Cys Glu Trp
Pro Cys Trp Glu
Pro Glu Cys Trp
Pro Glu Trp Cys
Pro Trp Cys Glu
Pro Trp Glu Cys
Gln Cys Phe His
Gln Cys His Phe
Gln Glu Glu Glu
Gln Phe Cys His
Gln Phe His Cys
Gln His Cys Phe
Gln His Phe Cys
Arg Asp Asp Glu
Arg Asp Glu Asp
Arg Glu Asp Asp
Val Asp Asp Trp
Val Asp Trp Asp
Val Trp Asp Asp
Trp Ala Glu Glu
Trp Cys Glu Pro
Trp Cys Pro Glu
Trp Asp Asp Val
Trp Asp Val Asp
Trp Glu Ala Glu
Trp Glu Cys Pro
Trp Glu Glu Ala
Trp Glu Pro Cys
Trp Pro Cys Glu
Trp Pro Glu Cys
Trp Val Asp Asp
Ethyl 1-(2-chlorophenyl)-5-(4-{4-[(3,5-dimethyl-1,2-oxazol-4-yl)c arbonyl]-1-piperazinyl}phenyl)-1H-pyrazole-3-carboxylate
N-acetylneuraminic Acid Methyl Ester 2,4,7,8,9-Pentaacetate
Idarubicin hydrochloride
C26H28ClNO9 (533.1452508000001)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Idarubicin hydrochloride is an anthracycline antileukemic agent. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts.
N-{2-[4-({3-Chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5H -pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-2-hydroxy-2-methylpropanamid e
C25H23ClF3N5O3 (533.1441434000001)
Melphalan flufenamide hydrochloride
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
((4-((4-Amino-m-tolyl)(4-(phenylimino)cyclohexa-2,5-dien-1-ylidene)methyl)phenyl)amino)benzenesulphonic acid
C32H27N3O3S (533.1773032000001)
2-Cyclohexyl-N-(2-{4-[5-(2,3-dichloro-phenyl)-2H-pyrazol-3-YL]-piperidin-1-YL}-2-oxo-ethyl)-2-guanidino-acetamide
C25H33Cl2N7O2 (533.2072658000001)
(2r)-1,1,1-Trifluoro-2-{4-[(2s)-2-{[(3s)-3-Methylmorpholin-4-Yl]methyl}-4-(Thiophen-2-Ylsulfonyl)piperazin-1-Yl]phenyl}propan-2-Ol
C23H30F3N3O4S2 (533.1629736000001)
(-)-latifolian A trifluoroacetate
A natural product found in Gnetum montanum.
[2-[2-(4-Fluorophenyl)ethylamino]-2-oxoethyl] 2-morpholin-4-yl-5-piperidin-1-ylsulfonylbenzoate
[4-[Bis(4-morpholinyl)phosphoryl]-1-methyl-2-pyrrolyl]-bis(4-morpholinyl)-sulfanylidenephosphorane
N-Benzoyl-N-(18-phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12,14,16-octaen-16-yl)benzamide
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
gammaGluCys(IAN)Glu
A tripeptide that consists of L-gamma-glutamyl-L-cysteinyl-L-glutamic acid in which the the cysteine side chain is substituted by a cyano(indol-3-yl)methyl group.
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
C27H33Cl2N3O4 (533.1847998000001)
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2R,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
N-[(2S,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
(2S,3S,4S,5R)-6-[3-[(4-acetamidophenyl)sulfonylamino]-2-phenylpyrazol-1-ium-1-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[4-(2-{[2-(3,4-dimethoxyphenyl)ethyl]-C-hydroxycarbonimidoyl}eth-1-en-1-yl)-2-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
(7R,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
C26H28ClNO9 (533.1452508000001)
4-[5-chloro-7-(3,5-dihydroxyhexanoyloxy)-3-[(1E,3E,5E)-hepta-1,3,5-trienyl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoic acid
C27H32ClNO8 (533.1816342000001)
Idarubicin hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Idarubicin hydrochloride is an anthracycline antileukemic agent. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts.
3-L-tryptophyl-AMP
An L-tryptophan derivative that is the ester obtained by formal condensation of the carboxy group of L-tryptophan with the 3-hydroxy group of AMP.
(15e)-5,8,18,21-tetrahydroxy-6-isopropyl-20-[2-(methylsulfanyl)ethyl]-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C22H35N3O6S3 (533.1687890000001)
(3s,6s,9r,13s,18as)-16-chloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O6 (533.2041002000001)
(2s)-2-{[(2r)-2-{[(4s)-4-amino-4-carboxy-1-hydroxybutylidene]amino}-3-{[cyano(1h-indol-3-yl)methyl]sulfanyl}-1-hydroxypropylidene]amino}pentanedioic acid
(9as,10r,13s,13as)-10,13,15,16-tetrahydroxy-8-methoxy-2-methyl-3-(sec-butyl)-6,7,9a,10,13,13a-hexahydro-9-oxa-2-azahexaphene-1,14-dione
astin D
C25H32ClN5O6 (533.2041002000001)
{"Ingredient_id": "HBIN017204","Ingredient_name": "astin D","Alias": "astin d","Ingredient_formula": "C25H32ClN5O6","Ingredient_Smile": "CCC(C(=O)NC(CO)C(=O)NC(CC(=O)NC(CC)C(=O)O)C1=CC=CC=C1)NC(=O)C2=CC=CN2","Ingredient_weight": "534","OB_score": "52.77764408","CAS_id": "153125-15-6","SymMap_id": "SMIT11507;SMIT14403","TCMID_id": "1932","TCMSP_id": "MOL010456","TCM_ID_id": "6548","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-5-hydroxy-1-[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid
C25H27NO12 (533.1533182000001)
3-{[(2s,3r,4s,5s,6r)-6-{[(3-carboxypropanoyl)oxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(4-hydroxyphenyl)-1λ⁴-chromen-1-ylium
16-chloro-3,13-diethyl-1,4,7,11-tetrahydroxy-6-(hydroxymethyl)-9-phenyl-3h,6h,9h,10h,13h,18h,18ah-pyrrolo[1,2-d]1,4,7,10,13-pentaazacyclohexadecan-14-one
C25H32ClN5O6 (533.2041002000001)
(2s,3s,4s,5s,6r)-3-(acetyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-n-methyl-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboximidic acid
5,8,18,21-tetrahydroxy-6-isopropyl-20-[2-(methylsulfanyl)ethyl]-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docosa-7,15,18,21-tetraen-3-one
C22H35N3O6S3 (533.1687890000001)
5-hydroxy-1-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydroindole-2-carboxylic acid
C25H27NO12 (533.1533182000001)